Surging Prevalence Of Animal Diseases Sparks Growth In The Veterinary Biologics Market Emerges as a Core Driver of the Veterinary Biologics Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Veterinary Biologics Market Through 2025?
The market size of veterinary biologics has seen a robust growth in the past few years. It is forecasted to expand from $12.67 billion in 2024 to $13.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to the growth in the historic period include disease outbreaks in animals, regulation and standardisation support, the requirement for food safety, trade globalization, and the financial importance of livestock.

What's the Projected Size of the Global Veterinary Biologics Market by 2029?
In the foroming years, the veterinary biologics market is projected to witness substantial growth, scaling up to $18.38 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. Factors such as the emergence of infectious diseases, shifts in disease patterns due to climate change, the advent of precision livestock farming, the holistic 'one health' concept, and rising trends in pet ownership are contributing to the growth expected within the forecast period. Key trends during this period encompass education and training initiatives, development of green and sustainable biologics, integration of digital health data, an increase in biologics for companion animals, and personalized, targeted therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Top Growth Drivers in the Veterinary Biologics Industry: What's Accelerating the Market?
The escalation of animal illnesses is anticipated to spur the advancement of the veterinary biologics market. Animal diseases encompass a range of maladies or health ailments impacting diverse animal species. The uptick in these diseases necessitates superior diagnosis and treatment solutions, achievable through the usage of veterinary biologics that employ immunological methods for disease treatment. For example, the European Center for Disease Prevention and Control, a health organization based in Sweden and part of the European Union, recorded a striking 2,467 avian flu outbreaks in poultry in October 2022, impacting about 48 million birds, with 187 cases identified in captive birds. In addition, in July 2022, the World Health Organization, a specialized agency of the United Nations headquartered in Switzerland, stated that rabies takes the lives of approximately 59,000 individuals annually in more than 150 countries, with Africa and Asia accounting for 95% of cases. Consequently, the surging instances of animal diseases are fuelling the exigency for veterinary biologics.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

What Trends Will Shape the Veterinary Biologics Market Through 2029 and Beyond?
Enterprises major in the arena of veterinary biologics are prioritizing the development of innovative biologics like vaccines to augment the health of animals and prevent diseases. Vaccines are specific substances that encourage the immune system to identify and combat specific disease-causing organisms, thus offering defense against infectious ailments by establishing acquired immunity. For example, Merck Animal Health, an American global corporation committed to animal health, in August 2024, introduced a research-based autogenous vaccine to address avian metapneumovirus (aMPV) type B. They received the U.S. Department of Agriculture (USDA)'s approval for its manufacturing and distribution. This vaccine was developed in partnership with Cambridge Technologies intending to combat the severe respiratory disorders caused by aMPV type B in poultry, leading to substantial financial losses since late 2023. Manufactured in a high-tech facility in Minnesota, the vaccine comes with an oil and water emulsion formulation that minimizes tissue reactions post-vaccination. This development fills an important void in the market as there were no commercially licensed vaccines available earlier.

What Are the Main Segments in the Veterinary Biologics Market?
The veterinary biologics market covered in this report is segmented -

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Diseases
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal

Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Which Top Companies are Driving Growth in the Veterinary Biologics Market?
Major companies operating in the veterinary biologics market include Bayer AG, Eli Lilly & Company, Evonik Industries AG, Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Vetoquinol, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

Which Regions Will Dominate the Veterinary Biologics Market Through 2029?
North America was the largest region in the veterinary biologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report :
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12366

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.